• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MENTOR TEXAS MENTOR MEMORYGEL BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MENTOR TEXAS MENTOR MEMORYGEL BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED Back to Search Results
Model Number 3543257
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Codes Capsular Contracture (1761); Seroma (2069); Deformity/ Disfigurement (2360)
Date of Event 05/26/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.  as such, the investigation will be closed.  if the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Mentor is submitting this report pursuant to the provisions of 21 cfr, part 803.  this report may be based on information which mentor has not been able to investigate or verify prior to the required reporting date.  this report does not reflect a conclusion by fda, mentor, or its employees that the report constitutes an admission that the device, mentor, or its employees caused or contributed to the potential event described in this report.Date of explant: (b)(6) 2023.Reason for device explant and/or reoperation: rupture.Manufacturer¿s reference number: (b)(4).
 
Event or Problem Description
It was reported that a 68-year-old caucasian female patient underwent a breast augmentation revision surgery with 325cc mentor memorygel breast implants.Post-operatively, the patient experienced bilateral rupture of her prostheses, which was confirmed via magnetic resonance imaging.As a result, the patient is scheduled for removal surgery on (b)(6) 2023.This report is for the left implant.Refer to manufacturing report number 1645337-2023-07514 for the contralateral event.
 
Additional Manufacturer Narrative
On september 01, 2023, mentor received additional information.Mentor became aware that the patient experienced bilateral capsular contracture of an unspecified baker grade.The patient's prosthesis was replaced with a 545cc mentor memorygel boost breast implant.Magnetic resonance imaging identified a trace of peri-implant fluid in the left breast.During the removal surgery, it was reported that 10cc of dark-colored seroma fluid was observed in the left breast.The left-sided capsule was removed and sent to pathology, along with the fluid, for anaplastic large cell lymphoma (alcl) and cd30 positive testing.No further information was provided.On september 12, 2023, mentor received additional information.The patient's date of implantation was updated to (b)(6) 2007.The identity of the impacted product was updated, as clarifying information was received.Size: 500cc brand name: mentor memorygel breast implant lot: 5670973.Catalog: 3545007.Serial number: (b)(6).Expiration date: 3/26/2011.Udi: (b)(4).Manufactured date: 1/16/2006.A manufacturing record evaluation (mre) was performed for the updated lot number, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Manufacturer¿s reference number: (b)(4).
 
Additional Manufacturer Narrative
On september 27, 2023, mentor received a device for evaluation.On september 28, 2023, mentor completed a visual inspection of the returned device.Device evaluation summary: visual analysis of the returned sample revealed that the breast implant have a tear on the posterior view within an area of siltex cracking, measuring approximately 2 cm.The evaluation determined that the possible cause of the rupture is consistent with normal wear.Siltex cracking is defined as a material separation occurring in the siltex layer and can eventually progress through the shell of siltex devices.Siltex cracking is ultimately a result of high stresses.Mentor concluded that the capsular contracture in the patient´s breast was the result of the body´s individual physiological response to the implantation of a foreign object in soft tissue.Capsular contracture is a known complication associated with these devices and is referenced in our current product insert data sheet.The american society of plastic surgeons recommends and encourages member surgeons to always submit breast implants, capsule, and effusion to pathology for examination.A seroma is a build-up of fluid around the implant.Symptoms from a seroma may include swelling, pain, and bruising.A seroma may occur soon after surgery, or any time later on, which would be referred to as a late seroma.While the body may absorb seromas, some may require surgery for drainage.You should consider the possibility of bia-alcl when a patient presents with late onset, persistent peri-implant seroma.In some cases, patients presented with capsular contracture or masses adjacent to the breast implant.When testing for bia-alcl, collect fresh seroma fluid and representative portions of the capsule, and sent to a laboratory with appropriate expertise for pathology test to rule out alcl, including immunohistochemistry testing for cd30 and alk (anaplastic lymphoma kinase).If your patient is diagnosed with peri-implant bia-alcl, develop an individualized treatment plan in coordination with a multidisciplinary care team.The national comprehensive cancer network (nccn) recommends surgical treatment that includes implant removal and complete capsulectomy ipsilaterally as well as contralaterally, where applicable.Manufacturer¿s reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MENTOR MEMORYGEL BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
Manufacturer (Section D)
MENTOR TEXAS
3041 skyway circle north
irving TX 75038
Manufacturer (Section G)
MENTOR TEXAS
3041 skyway circle north
irving TX 75038
Manufacturer Contact
kate karberg
3041 skyway circle north
irving, TX 75038
3035526892
MDR Report Key17198258
Report Number1645337-2023-07513
Device Sequence Number17527824
Product Code FTR
UDI-Device Identifier00081317000730
UDI-Public00081317000730
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P030053
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2007
Device Explanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/26/2011
Device Model Number3543257
Device Catalogue Number3545007
Device Lot Number5670973
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 06/08/2023
Supplement Date Received by Manufacturer09/01/2023
09/27/2023
Initial Report FDA Received Date06/26/2023
Supplement Report FDA Received Date09/19/2023
10/06/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/27/2006
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age68 YR
Patient SexFemale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-